EUVIMEDEUVIMED entdecken
Crossref

Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

Pranita D Tamma iD, Robert A Bonomo, Emily L Heil, Julie Ann Justo, Michael J Satlin, Amy J Mathers

Clinical Infectious Diseases · 08.08.2026

DOI: 10.1093/cid/ciag481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 08.08.2026. Verfasst von Pranita D Tamma und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 665 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Infectious Diseases Society of America (IDSA) is committed to delivering timely, evidence-informed guidance on the management of antimicrobial-resistant (AMR) infections. This updated IDSA AMR Guidance document provides treatment suggestions for infections caused by extended-spectrum β-lactamase–producing Enterobacterales (ESBL-E), AmpC β-lactamase–producing Enterobacterales (AmpC-E), carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa with difficult-to-treat resistance (DTR P. aeruginosa), carbapenem-resistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia. This update replaces earlier versions of the IDSA AMR Treatment Guidance.

Methods

A panel of 6 infectious diseases specialists with expertise in AMR convened to address important questions regarding the treatment of infections due to ESBL-E, AmpC-E, CRE, DTR P. aeruginosa, CRAB, and S. maltophilia. Given geographic variability in AMR epidemiology and antibiotic availability, the IDSA AMR Guidance focuses on clinical practice in the United States.

Results

Preferred and alternative treatment strategies are outlined with accompanying rationales, based on pathogen identification and in vitro susceptibility data. Suggestions addressing empiric therapy, transition to oral therapy, duration of treatment, and other management considerations are briefly discussed. While applicable to both adult and pediatric populations, specific dosing guidance is only provided for adults.

Conclusions

The field of AMR is highly dynamic. This document is current as of 1 March 2026 and will be updated periodically. The most up-to-date version of this document, including date of publication, is available at www.idsociety.org/practice-guideline/amr-guidance/.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosaStenotrophomonas maltophiliaAmpCCRABESBLcarbapenem-resistant Enterobacterales

Autor:innen und Institutionen

  • University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Northeast Ohio Health Care System, Louis Stokes Cleveland Veterans Affairs Medical Center & Case Western Reserve University, Cleveland, Ohio, USA.
  • University of Maryland, Baltimore, Maryland, USA.
  • Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Weill Cornell Medicine, New York, NY, USA.
  • University of Virginia, Charlottesville, Virginia, USA.

ORCID-Profile: Pranita D Tamma

Zitieren

APA

Tamma, P. D., Bonomo, R. A., Heil, E. L., Justo, J. A., Satlin, M. J., & Mathers, A. J. (2026). Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag481

Vancouver

Tamma PD, Bonomo RA, Heil EL, Justo JA, Satlin MJ, Mathers AJ. Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag481

BibTeX
@article{Tamma2026,
  author = {Tamma, Pranita D and Bonomo, Robert A and Heil, Emily L and Justo, Julie Ann and Satlin, Michael J and Mathers, Amy J},
  title = {Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag481}
}
Kostenlos starten →